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Aim: To evaluate risk factors for lymphoedema development in the upper and lower limbs and to propose
a model that predicts risk of lymphoedema after lymphadenectomy.
Patients: We studied 84 patients who had undergone radical lymphadenectomies for cutaneous mela-
noma from 1990 to 2008.
Methods: The patients included underwent an evaluation that consisted of measurement of limb volume
using perimetry, application of the manually acquired perimetric data to the truncated-cone formula,
and data from medical records.
Results: Using multivariate analysis, we obtained the following risk factors for the development of
lymphoedema: reconstruction with graft (p¼ 0.013), Breslow depth >4 mm (p¼ 0.029), ilioinguinal
lymphadenectomy (p¼ 0.037) and wound infection (p¼ 0.036). We assigned points to each factor as
dictated by the value of the regression coefﬁcient, as follows: infection (1 point), ilioinguinal lympha-
denectomy and Breslow >4 mm (2 points each) and reconstruction with graft (3 points). The mathe-
matical model for predicting lymphoedema risk in the limb ipsilateral to the lymphadenectomy was
based on risk groups, deﬁned by score: low risk¼ 0 point (for which we calculated an 8.3% chance of
developing lymphoedema), intermediate risk¼ 1e2 points (26.8%), high risk¼ 3 points (52.9%) and very
high risk¼ 4 or more points (88.9%).
Conclusions: This study identiﬁed a melanoma thickness >4 mm, graft reconstruction, ilioinguinal lym-
phadenectomy and infection as risk factors for lymphoedema. From these factors, we constructed
a mathematical model that successfully predicted risk of post-lymphadenectomy lymphoedema. The
combined presence of these risk factors increased the chance of developing lymphoedema.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Lymphoedema is a chronic disorder inwhich the demand on the
lymphatic system to drain lymph away greatly exceeds its capacity,
causing a progressive increase in the volume of the limb.1
Melanoma treatment consists of tumour resection followed by
analysis of the anatomical and pathological specimen.2,3
Regional lymphadenectomy is indicated for patients who have
positive sentinel lymph nodes or clinically suspect lymph nodes.
The primary complications following lymphadenectomy are lym-
phoedema, infection, seroma, scar dehiscence, restricted range of
movement of nearby joints and cutaneous numbness. Rates of
lymphoedema after surgery vary from 2 to 19% in the upper
limbs4e9 and 18 to 64% in the lower limbs.4,5,8e14panholi).
ciates Ltd. Published by Elsevier LtLymphoedema is the most common source of morbidity after
axillary and inguinal lymphadenectomies5,7,10,15e17 and has nega-
tive physical, social and emotional repercussions on patients’
quality of life.18
Few studies have sought to predict risk factors for development
of limb lymphoedema after inguinal or axillary lymph node
dissection performed as treatment for cutaneous melanoma. The
impact of different treatment types and their complications has not
been clariﬁed by existing studies.
The aims of this study were to evaluate the risk factors for
lymphoedema development in the limbs and to propose a mathe-
matical model that can predict the risk of limb lymphoedema after
lymphadenectomy.2. Patients and methods
The study was developed for patients diagnosed with cutaneous melanomawho
were admitted to the Department of Skin Oncology of AC Camargo Hospital betweend. All rights reserved.
Table 1
Univariate analysis of risk factors for lymphoedema.
Lymphoedema p-value
No Yes
(n ¼ 51) (n ¼ 33)
n % n %
Radiotherapy 6 11.8 7 21.2 0.242
Chemotherapy 7 13.7 6 18.2 0.581
Perfusion or infusion in the limb 3 5.9 5 15.2 0.253
Graft reconstruction 5 9.8 11 33.3 0.007
Flap reconstruction 6 11.8 3 6.1 1.000
Infection 10 19.6 15 45.5 0.011
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radical lymph node dissection for cutaneous melanoma and who had had surgery
more than six months earlier were included in this study. We excluded patients who
did not give consent or who had undergone limb amputation or bilateral lymph
node dissection that made perimetric comparison of the limbs impossible.
We measured limb volume via manual perimetry, using a tape measure to ﬁnd
limb circumference. The lower limbs were measured every 10 cm from the sole up to
the seventhmeasurement.19,20 For upper limbs, measurements were taken at 14 and
7 cm above the interarticular line through the elbow, and at 7, 14 and 21 cm below
it.21 A single researcher measured all patients to prevent differences in tension on
the tape. Perimetry of both upper limbs was performed for patients who had had
axillary dissection, and in both lower limbs in patients with inguinal lymph node




C1 C2þ C12 þ C22

12p
where, V ¼ volume of the ﬁnal segment of the limb, C1 and C2 ¼ circumference
measured between the points, and h ¼ distance between the circles (C1 and C2 in
each segment), measured in centimetres.
Upper limb lymphoedema was considered to be present when the difference
between the volumes of the two upper limbs was >10%7,11,22,23 while lower limb
lymphoedemawas deﬁned as a difference of>6.5%.10,11 The values for the upper and
lower limbs were based on volumes found by displacement of water, since no
studies exist that give a value for diagnosis of lymphoedema based on limb volumes
calculated by the truncated-cone formula.
Clinical, surgical, pathological and follow-up-related variables were collected
from medical records and patient interviews.
SPSS 15.0 was used for all statistics. Analysis of risk factors for onset of post-
operative lymphoedema was performed by means of the chi-square test or
Fisher’s exact test, depending on the expected values in the contingency tables.
Numerical data were compared between groups using the ManneWhitney test. A
forward stepwise logistic regression was used to identify the risk factors for
lymphoedema. A scoring system to predict risk of lymphoedema was developed
using the independent risk factors identiﬁed in the multivariate analysis. For our
purposes, the range of the regression coefﬁcients was calculated using the
difference between the minimum and maximum values. This range was divided
into three equal parts. Each risk factor was assigned points as dictated by the
regression coefﬁcients. Variables for which the regression coefﬁcient fell in the
ﬁrst third of the range received one point; in the second third, two points; and in
the last third, three points. No points were given when no risk factor was present.
A ﬁnal score was calculated for each patient as the sum of these points. Adher-
ence to normality was veriﬁed using the KolmogoroveSmirnov and ShapiroeWilk
tests for the following variables: Breslow, margin expansion, number of positive
lymph nodes and number of dissected lymph nodes. The signiﬁcance level was set
to 5%.
The project was approved by the Research Ethics Committee of AC Camargo
Hospital.Table 2
Relation between the numeric variables and the prevalence of lymphoedema.
Lymphoedema p value
No Yes
(n ¼ 51) (n ¼ 33)
Median Range Median Range
Breslow (mm)a 1.95 0.2e6.1 3.4 0.8e38.0 0.112
Margin expansion (cm)b 2 1e3 2 1e3.5 0.013
Number of positive lymph nodes 1 0e21 1 0e12 0.438
Number of dissected lymph nodes 23 2e67 18 4e51 0.041
a 15 cases without information.
b 38 cases without information.3. Results
Themajority of the patients werewomen (48 cases, or 57.1%), 73
patients were white (86.9%), 61 had dark hair (72.6%), and 66 had
dark eyes (78.6%).
The average patient age at the time of surgery was 47.2 years
(standard deviation 16.7) ranging from 5 to 80 years. On the day of
assessment for this study, patients’ average age was 52.5 (standard
deviation) 16years, ranging from10 to81years. The timeelapsed since
lymphadenectomy ranged from 6 to 117.8 months (median¼ 44).
We evaluated 84 patients (40 (47.6%) with axillary, 21 (25%) with
inguinal and 23 (27.4%) with ilioinguinal lymphadenectomy).
The prevalence of lymphoedema was 17.5% in the upper limbs
and 59.1% in the lower limbs (42.9% in inguinal lymphadenectomy
and 73.9% in ilioinguinal).
Univariate analysis of risk factors for lymphoedema is shown in
Table 1 and in Table 2, the relation between the prevalence of
lymphoedema and the numeric variables.
Multivariate analysis identiﬁed the following risk factors for
lymphoedema: ilioinguinal lymphadenectomy (OR ¼ 5.7; p ¼
0.042), wound infection (OR ¼ 4.3; p ¼ 0.040), graft reconstruction
(OR ¼ 7.8; p ¼ 0.016) and Breslow depth greater than 4 mm
(OR¼5.6;p¼0.030) (Table 3). These variableswerealso adjusted for
radiotherapy status and number of dissected lymph nodes.Table 4 shows the prevalence of lymphoedema according to the
number of points scored. Patients were classiﬁed into four risk
groups for lymphoedema depending on their score. A high preva-
lence of lymphoedema was observed in patients with high scores
(Table 5).
The ability of the score to predict risk of lymphoedema
(according to criteria found in the literature) was evaluated with
a ROC curve (Fig. 1). This analysis found an area under the curve of
0.82 (95% CI: 0.71e0.93), sensitivity of 70.8% (95% CI: 48.9e87.3%)
and speciﬁcity of 80.0% (95% CI: 65.4e90.4%).
4. Discussion
This study had several limitations, and it would have been more
ideal to study a larger number of participants in a prospective,
multicenter trial. However, it is very difﬁcult to reach the desired
numberof patients and to achieve a follow-upgreater thanﬁveyears.
Of note is the mathematical model to predict lymphoedema
which is proposed in this study and which has never been previ-
ously attempted.
In this study, multivariate analysis yielded local (Breslow depth,
graft reconstruction, and wound infection) and regional (type of
lymphadenectomy) risk factors for lymphoedema. Patients with
melanoma thickness greater than 4 mm were at high risk for
developing lymphoedema. However, the development of lym-
phoedema was not exclusively a matter of tumour biology, but
instead of the treatment offered to these patients. It is possible that
a more extensive resection causes greater damage and reduction of
ﬂow through the lymphatic system and consequently results in
a greater chance of developing lymphoedema. In addition, more
lymph nodes are often involved which may be of greater size or
may be associated with in-transit metastasis. Moreover, the limb
is often subjected to radiation and chemotherapeutic infusion.
Multivariate analysis was performed after replacing the variable
representing the Breslow depth with a variable for surgical margin,
but the model did not ﬁt well, such that surgical margin was not
identiﬁed as a risk factor; however it trended towards statistical
Table 3














1.74 13.4 5.7 1.1e30.3 0.042
Wound infection 1.46 3.4 4.3 1.1e17.5 0.040
Reconstruction with
graft
2.05 4.6 7.8 1.5e41.2 0.016
Breslow depth >4 mm 1.73 1.5 5.6 1.2e26.9 0.030
a Variables adjusted by radiotherapy and number of lymph nodes dissected.
b The regression coefﬁcients ranged from 1.46 to 2.05 (range ¼ 0.59). The points
assigned to variables according to the regression coefﬁcients (b) were:
 b ¼ 1.46e1.65 ¼ 1 point  b ¼ 1.66e1.85 ¼ 2 points  b ¼ 1.86e2.05 ¼ 3 points.
Table 5
Prevalence of limb lymphoedema stratiﬁed by risk groups deﬁned on the basis of the
score.





Low risk 0 24 8.3%
Intermediate
risk
1 or 2 19 26.3%
High risk 3 17 52.9%
Very high risk 4 or
more
9 88.9%
(Chi-square test: p < 0.001).
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be that in nearly half of our cases, no information on the surgical
margin had been documented in medical records.
Reconstruction with a graft was also identiﬁed as an indepen-
dent risk factor for lymphoedema. This type of reconstruction
promotes local ﬁbrosis, with consequent decrease in lymphatic
ﬂow. Thus, a patient who is subjected to extensive resection and
reconstruction with a graft would have two risk factors for lym-
phoedema development, because both can obstruct lymphatic
drainage channels.
Bergmann21 and Vries10 previously found that surgical infection
increases the risk of developing lymphoedema. The high risk for
lymphoedema due to wound infection observed in this study was
similar to values fromother investigations.4,8e10,24 Results from this
analysis suggest that infection may increase risk for lymphoedema
via enhanced inﬂammatory ﬁbrosis of the lymphatic vessels in the
lymph node basin, which worsens the lymphatic drainage of the
limb.
The site of lymphadenectomy is clearly a risk factor for lym-
phoedema onset, due to the greater number of lymph nodes
dissected and the number of surgical procedures performed.
Allan14 asserted that the risk of lymphoedema was no different in
inguinal vs. pelvic lymphadenectomy, but that the diagnosis was
made subjectively (by criteria in medical records) and suggested
further that ilioinguinal lymphadenectomy be performed routinely
for palpable (clinically metastatic) nodes in the inguinal region.
Spillane25 also reported no difference between the two types of
lymphadenectomies, having diagnosed lymphoedema via opto-
electronic volumetry and perimetry. Although measurements were
made with perimetry, the analysis was not performed with the
truncated-cone formula, but by summing the circumferences. In
this study, patients who underwent ilioinguinal lymphadenectomy
were at high risk for lymphoedema. However, inguinal vs. iliac
lymphadenectomy was not found to be an independent risk factor.
This result is not surprising, since removing the inguinal and pelvic
lymph nodes leaves few alternative lymphatic pathways for the
ﬂow of lymph from the lower limbs. It is believed that when onlyTable 4
Prevalence of limb lymphoedema according to number of points scored.
Number of points
scored










6 5 100%the inguinal lymph nodes are removed, the lymph can still ﬂow
through the superﬁcial lymphatic plexus to the pelvic lymph nodes.
However when the pelvic lymph nodes are removed, few alterna-
tive routes for lymph ﬂow remain.
Another risk factor shown to contribute to lymphoedema is
radiotherapy directed at the lymphadenectomy bed.5,10,26e29 For
this reason, it was included in the multivariate model as an
adjustment variable, although it was not signiﬁcant in univariate
analysis. Even in themultivariate model, the presence or absence of
radiotherapy was not associated with lymphoedema, most likely
because only a small number of our patients underwent post-
operative radiotherapy. In larger samples, it is likely that radiation
treatment would be identiﬁed as a risk factor in a multivariate
model.
The mathematical model for predicting risk of limb lymphoe-
dema after lymphadenectomy was based on risk groups deﬁned by
a score. Performing this calculation confers the advantage of
knowing in advance which patients have a greater chance of
developing lymphoedema and therefore having the opportunity to
institute more intensive preventive measures.
For example, a patient who undergoes ilioinguinal lymphade-
nectomy with subsequent site infection has a 52.9% chance of
developing lymphoedema, compared with 8.3% for a patient who
has an axillary dissection with infectious sequelae.
In summary, this study identiﬁed the following risk factors for
lymphoedema: ilioinguinal lymphadenectomy, reconstructionwith
graft, Breslow depth greater than 4 mm and post-operative wound
infection. A combination of risk factors increases the chance ofFig. 1. Ability of the score to predict risk of lymphoedema.
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depth >4 mm) usually require extensive lymphadenectomy and
graft reconstruction, the two factors that most increase the risk of
lymphoedema. The application of a mathematical model to predict
the risk of lymphoedema is feasible for the oncologist, and it is able
to identify patients who should havemore careful, earlymonitoring
and intensive physiotherapy. However, the results found in this
study must be validated in other studies.
Conﬂict of interest
There is no conﬂict of interest.
Funding source
This study was supported by the following Brazilian scientiﬁc
agencies: FAPESP (Fundação de Amparo à Pesquisa do Estado de
São Paulo) and CNPq (Conselho Nacional de Desenvolvimento
Cientíﬁco e Tecnológico).
Ethical approval
The project was approved by the Research Ethics Committee of
AC Camargo Hospital.References
1. Weiss JM, Spray B. The effect of complete descongestive therapy on the quality
of life of patients with peripheral lymphoedema. Lymphology
2002;2002(35):46e58.
2. Duprat JP, Silva DCP, Coimbra FJF, Lima IA, Lima EN, Almeida OM, et al. Sentinel
lymph node biopsy in cutaneous melanoma: analysis of 240 consecutive cases.
Plast Reconstr Surg 2005;115:1944e51.
3. Roberts DLL, Anstey AV, Barlow RJ, Cox NH, Newton Bishop JA, CORRIE PG, et al.
U.K. Guidelines for the management of cutaneous melanoma. Br J Dermatol
2002;146(1):7e17.
4. Lawton G, Rasque H, Ariyan S. Preservation of muscle fascia to decrease lym-
phoedema after complete axillary and ilioinguinofemoral lymphadenectomy
for melanoma. J Am Coll Surg 2002;195(3):339e51.
5. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, et al.
Complications associated with sentinel lymph node biopsy for melanoma. Ann
Surg Oncol 2003;10:676e80.
6. Starritt EC, Joseph D, McKinnon G, Lo SK, Wilt JHW, Thompson JF. Lymphoe-
dema after complete axillary node dissection for melanoma. Ann Surg
2004;240:866e74.
7. Vries M, Vonkeman WG, Ginkel RJ, Hoeskstra HJ. Morbidity after axillary
sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg
Oncol 2005;31(7):778e83.
8. van Akkooi ACJ, Bouwhuis MG, van Geel AN, Hoedemaker R, Verhoef C,
Grunhagen DJ, et al. Morbidity and prognosis after therapeutic lymph node
dissections for malignant melanoma. Eur J Surg Oncol 2007;33(1):102e8.
9. Kretschemer L, Thoms K, Peeters S, Haenssle H, Bertsch HP, Emmert S. Post-
operative morbidity of lymph node excision for cutaneous melanoma-sentinel
lymphonodectomy versus complete regional lymph node dissection.Melanoma
Res 2008;18:16e21.10. Vries M, Vonkeman WG, Ginkel RJ, Hoeskstra HJ. Morbidity after inguinal
sentinel lymph node biopsy and completion lymph node dissection in patients
with cutaneous melanoma. Eur J Surg Oncol 2006;32(7):785e9.
11. Bass PC, Koops S, Hoekstra HJ, Bruggen JJ, Weele LT, Oldhoff J. Groin
dissection in the treatment of lower-extremity melanoma. Arch Surg
1992;127:281e6.
12. Sabel MS, Grifﬁth KA, Arora A, Shargorodsky J, Blazer 3rd DG, Rees R, et al.
Inguinal node dissection for melanoma in the era of sentinel lymph node
biopsy. Surgery 2007;141(6):728e35.
13. Spillane AJ, Saw RPM, Tucker M, Dip G, Byth K, Thompson JF. Deﬁning lower
limb lymphoedema after inguinal or ilio-inguinal dissection in patients with
melanoma using classiﬁcation and regression tree analysis. Ann Surg
2008;248(2):286e93.
14. Allan CP, Hayes AJ, Thomas JM. Ilioinguinal lymph node dissection for palpable
metastatic melanoma to the groin. ANZ J Surg 2008;78(11):982e6.
15. Serpell JW, Came P, Bailey M. Radical lymph node dissection for melanoma.
ANZ J Surg 2003;73:294e9.
16. Roaten JB, Pearlman N, Gonzalez R, Gonzalez R, McCarter MD. Identifying risk
factors for complications following sentinel lymph node biopsy for melanoma.
Arch Surg 2005;140(1):85e9.
17. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP,
et al. Prevalence of lymphoedema in women with breast cancer 5 years after
sentinel lymph node biopsy or axillary dissection: objective measurements.
J Clin Oncol 2008;26(32):5213e9.
18. Moffat CJ, Franks PJ, Doherty DC, Williams AF, Badger C, Jeffs E, et al. Lym-
phoedema: an underestimated health problem. Q J Med 2003;96:731e8.
19. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-
extremity volume estimates: comparison of calculated volume derived from girth
measurements and water displacement volume. Phys Ther 2003;83(2):134e45.
20. Casley-Smith JR. Measuring and representing peripheral oedema and its
alterations. Lymphology 1994;27(2):56e70.
21. Bergmann A, Mattos IE, Koifman RJ. Incidência e fatores de risco do linfedema
após tratamento cirúrgico para câncer de mama: estudo de uma coorte hos-
pitalar. Dissertação de Doutorado. Escola Nacional de Saúde Pública. 2005,
Fundação Oswaldo Cruz, 2005: Rio de Janeiro.
22. Kosir MA, Rymal C, Koppolu P, Hryniuk L, Darga L, Du W, et al. Surgical
outcomes after breast cancer surgery: measuring acute lymphoedema. J Surg
Res 2001;95(2):147e51.
23. Haid A, Kuehn T, Konstantiniuk P, Köberle-Wührer R, Knauer M, Kreienberg R,
et al. Showder-arm morbidity following axillary dissection and sentinel node
only biopsy for breast cancer. Eur J Surg Oncol 2002;28:705e10.
24. Guggenheim MM, Hug U, Jung FL, Rousson V, Aust MC, Calcagni M, et al.
Morbidity and recurrence after completion lymph node dissection following
sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg
2008;247(4):687e93.
25. Spillane AJ, Saw R, Tucker M, Dip G, Byth K, Thompson JF. Deﬁning lower limb
lymphoedema after inguinal or ilio-inguinal dissection in patients with
melanoma using classiﬁcation and regression tree analysis. Ann Surg
2008;248:286e93.
26. Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansﬁeld PF, Kim KB, et al.
A critical assessment of adjuvant radiotherapy for inguinal lymph node
metastases. Ann Surg Oncol 2004;11:1079e84.
27. Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, et al.
Combined-modality therapy for patients with regional nodal metastases from
melanoma. Int J Radiat Oncol Biol Phys 2006;64:106e13.
28. Burmeister BH, Smithers BM, Davis S, Spry N, Johnson C, Krawitz H, et al.
Radiation therapy following nodal surgery for melanoma: an analysis of late
toxicity. ANZ J Surg 2002;72:344e8.
29. Curry J, Smith JG, Bishop M, Ainslie J. Nodal radiation therapy for metastatic
melanoma. Int J Radiat Oncol Biol Phys 1999;44:1065e9.
